The United States Patent and Trademark Office (USPTO) has issued patent US12582849B2, titled "Determining ultrasound-based blood-brain barrier opening or increased permeability using physiologic signals." The patent, assigned to Cordance Medical Inc., covers devices, methods, and systems that utilize physiologic signals to assess blood-brain barrier (BBB) opening or increased permeability during ultrasound-based procedures.

This patent represents a new intellectual property grant for a specific medical technology. While not a regulatory rule imposing obligations on industry, it signifies innovation in the field of diagnostic and therapeutic devices for neurological conditions. Companies operating in the medical device or pharmaceutical sectors, particularly those involved in neurological treatments or ultrasound-based therapies, may need to be aware of this patent for competitive and licensing considerations.